首页> Scientific reports> Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.

Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.

导出 LinkOut

翻译打印收藏纠错

第一作者： Malaney R,O'Connell

第一单位： Departments of Neuroscience and Cell Biology, UTMB, Galveston, TX.

作者： Malaney R,O'Connell ^[1] ; Shubhashish,Sarkar ^[1] ; Gurinder K,Luthra ^[2] ; Yoshinaga,Okugawa ^[3] ; Yuji,Toiyama ^[4] ; Aakash H,Gajjar ^[5] ; Suimin,Qiu ^[6] ; Ajay,Goel ^[7] ; Pomila,Singh ^[1]

作者单位： Departments of Neuroscience and Cell Biology, UTMB, Galveston, TX. ^[1] Gastroenterology Division in Internal Medicine, UTMB, Galveston, TX. ^[2] Gastrointestinal Cancer Research Laboratory, Division of Gastroenterology, Department of Internal Medicine, Charles A. Sammons Cancer Center and Baylor Research Institute, Baylor University Medical Center, Dallas, Texas, USA.;Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Graduate School of Medicine, Mie University, Mie 514-8507, Japan. ^[3] Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Graduate School of Medicine, Mie University, Mie 514-8507, Japan. ^[4] Surgery, UTMB, Galveston, TX. ^[5] Pathology, UTMB, Galveston, TX. ^[6] Gastrointestinal Cancer Research Laboratory, Division of Gastroenterology, Department of Internal Medicine, Charles A. Sammons Cancer Center and Baylor Research Institute, Baylor University Medical Center, Dallas, Texas, USA. ^[7]